Weekly Market Recap – Week Ending January 16, 2026 U.S. equity markets have begun 2026 with relatively muted index-level performance, but beneath the surface, leadership dynamics continue to evolve meaningfully. The early days of the year are reinforcing the rotation trends that emerged late in 2025, as investors increasingly favor smaller-capitalization stocks, value-oriented strategies, and … Read more
Weekly Market Recap – Week Ending December 05, 2025 Market sentiment steadied this week as major ETFs posted measured, broad-based gains following the volatility of November. Technology again led the advance, with QQQM up 1.34%, while cyclical sectors such as Industrials (XLI) and Technology (XLK) outperformed with strong weekly moves. Defensive pockets, particularly Utilities (XLU) … Read more
Weekly Market Recap – Week Ending November 14, 2025 The past week saw a clear defensive tilt across major ETFs, with only a handful of pockets showing resilience. Utilities, consumer staples, and select dividend strategies managed modest gains, while growth-heavy benchmarks such as QQQM and technology-sector ETFs slipped more than 2%. At the individual-stock level, … Read more
The Consumer Discretionary sector of the Global Industry Classification Standard (GICS) was established in 1999 to represent cyclical industries. It has undergone several significant revisions to reflect the evolution of the global economy, primarily in 2018 and 2023, as business models shifted. All research 5,000+ stocks and 700+ ETFs updated on www.ValuEngine.com When GICS was … Read more
The Finance Sector is ranked as #3 among the 15 we cover for year-ahead returns by the ValuEngine forecast model. Finance sector stocks and ETFs along with the previously profiled utilities sector are generally perceived as stodgy stocks that are most commonly bought by older investors for dividend yield. However, that has not been true … Read more
I will often feature stocks rated buy or strong buy in highly rated sectors. This one is a departure. The healthcare sector is most commonly represented by the Select Sector SPDR Healthcare ETF, XLV. It faced a challenging year in 2024, underperforming the S&P 500 Index by a staggering 22.4%. This massive performance shortfall resulted … Read more
Part I of this article (posted on Blog.ValuEngine.com on May 22, click HERE) started with Louis Bachelier’s work from 1900 and covered all the theoretical work done up to and including William Sharpe, Ph.D.’s seminal work in 1964. However, none of that early research had yet been applied successfully to actual investments in any meaningful … Read more
The history of quantitative analysis goes back far before computers, and this work leads directly into how the field progresses once computers can be applied. In this first post we explore the history and development of quantitative analysis as it applied to finance in the pre-computer world of the early through mid 20th century. Actively … Read more
Looking at this week’s list of stocks rated 5 (Strong Buy) from ValuEngine for year-ahead performance, I note that there are a number of relatively well-known large cap and midcap stocks that meet my minimum criteria as appropriate for conservative institutional-quality portfolios. As we will see, all five are in popular large cap and midcap … Read more
There was a hilarious Match.com commercial at the end of 2020 where the year, portrayed by Kristen Bell, became a perfect match for Satan. This is exactly how many equity investors felt about the first half of 2022. 2020 turned out to be a good year for the market as the government stepped in with … Read more